Herbs (Global Traditional) · African
Hibiscus (Hibiscus sabdariffa) (Hibiscus sabdariffa)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Hibiscus sabdariffa contains anthocyanins and other polyphenolic compounds that may support cardiovascular health through cholesterol metabolism modulation. Preclinical studies suggest it inhibits cholesterol absorption and reduces hormone-sensitive lipase activity.
Hibiscus sabdariffa is a plant in the Malvaceae family, commonly known as roselle, with its dried calyces (sepals surrounding the seed pod) used for medicinal and food purposes. Native to Africa and cultivated globally including Guinea-Bissau, the mature calyces are harvested and dried, then typically extracted through hot water infusion or hydroethanolic methods to yield polyphenols and anthocyanins.
The research dossier explicitly states that search results lack specific details on human clinical trials, RCTs, or meta-analyses, with no PubMed PMIDs for human studies provided. While sources reference ethnobotanical and preclinical bioactivities including antioxidant, antihypertensive, anti-diabetic, and anti-cancer effects, no human trial data is available.
No clinically studied dosage ranges for extracts, powders, or standardized forms are specified in the available research. No standardization levels used in studies are mentioned. Consult a healthcare provider before starting any new supplement.
Hibiscus sabdariffa calyces (dried) provide approximately 49 kcal per 100g. Macronutrients: carbohydrates ~12g/100g (predominantly organic acids and polysaccharides), protein ~1.1g/100g, fat ~0.1g/100g, dietary fiber ~2.3g/100g. Key organic acids: citric acid (13–17% dry weight, primary acidulant), malic acid (~3% dry weight), tartaric acid, and hibiscus acid (hydroxycitric acid lactone, ~15% dry weight — a distinctive marker compound). Micronutrients: vitamin C (ascorbic acid) ~12–18mg/100g fresh calyx (significantly reduced in dried/processed forms); iron ~8.5mg/100g dried (high but bioavailability limited to non-heme form, enhanced by co-consumed vitamin C); calcium ~215mg/100g dried; magnesium ~51mg/100g; phosphorus ~37mg/100g; potassium ~208mg/100g; zinc ~0.6mg/100g. Bioactive compounds: total anthocyanins ~1.5–2.5g/100g dried calyx (delphinidin-3-sambubioside and cyanidin-3-sambubioside are primary pigments, comprising ~60–80% of total anthocyanin fraction); total polyphenols ~100–200mg GAE/100g dried; flavonoids including quercetin, luteolin, and kaempferol glycosides (~30–50mg/100g); protocatechuic acid (a key anthocyanin metabolite linked to antioxidant activity). Bioavailability notes: anthocyanin bioavailability is relatively low (~1–2% absorption rate as with most dietary anthocyanins); iron absorption is inhibited by co-present polyphenols; organic acids improve mineral solubility in aqueous extracts (tea/infusion); hibiscus acid (hydroxycitric acid lactone) is water-soluble and well-extracted in standard infusions at ~80–95°C.
Hibiscus sabdariffa's anthocyanins and polyphenolic compounds inhibit cholesterol absorption in the intestinal tract and reduce hormone-sensitive lipase activity in adipose tissue. These compounds also scavenge free radicals through their antioxidant properties, potentially supporting vascular endothelial function. The bioactive constituents interact with lipid metabolism pathways to influence cardiovascular parameters.
Current evidence for hibiscus sabdariffa consists primarily of preclinical studies examining cardiovascular mechanisms. Laboratory research has demonstrated cholesterol absorption inhibition and hormone-sensitive lipase reduction, but human clinical trials are lacking in the available data. Traditional ethnobotanical reports suggest antihypertensive effects, though controlled human studies have not been provided to substantiate these claims. The evidence base remains limited to preliminary research requiring human validation.
Hibiscus sabdariffa is generally considered safe when consumed as a traditional herbal tea or supplement. Potential interactions may occur with antihypertensive medications due to reported blood pressure effects, though clinical data is limited. Individuals with existing cardiovascular conditions should consult healthcare providers before supplementation. Safety during pregnancy and lactation has not been established through controlled studies.
